SUVEN LIFE SCIENCES
Back to Balance Sheet
|
SUVEN LIFE SCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1.71 Cr | ₹1.35 Cr | ₹2.46 Cr | ₹3.58 Cr | ₹4.50 Cr |
What is the latest Total Non-Current Liabilities ratio of SUVEN LIFE SCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹1.71 Cr |
| Mar2024 | ₹1.35 Cr |
| Mar2023 | ₹2.46 Cr |
| Mar2022 | ₹3.58 Cr |
| Mar2021 | ₹4.50 Cr |
How is Total Non-Current Liabilities of SUVEN LIFE SCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.71 Cr | 27.12 | |
| Mar2024 | ₹1.35 Cr | -45.33 | |
| Mar2023 | ₹2.46 Cr | -31.13 | |
| Mar2022 | ₹3.58 Cr | -20.61 | |
| Mar2021 | ₹4.50 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹9,019.2 Cr | -6.5% | 20.3% | 14.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | -6.5% |
20.3% |
14.5% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses